|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500113905 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-04 11:38:27 |
|
注册时间: Date of Registration: |
2025-12-04 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
Er:YAG激光在牙周膜切割术中的应用研究 |
|
Public title: |
A Study on the Application of Er:YAG Laser in Periodontal Ligament Dissection |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
Er:YAG激光在牙周膜切割术中的应用研究 |
|
Scientific title: |
A Study on the Application of Er:YAG Laser in Periodontal Ligament Dissection |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陶疆 |
研究负责人: |
陶疆 |
|
Applicant: |
Tao Jiang |
Study leader: |
Tao Jiang |
|
申请注册联系人电话: Applicant telephone: |
+86 53315202 |
研究负责人电话: Study leader's telephone: |
+86 53315202 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
taojiang_doctor@sjtu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
taojiang_doctor@sjtu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市市辖区黄浦区制造局路639号 |
研究负责人通讯地址: |
上海市市辖区黄浦区制造局路639号 |
|
Applicant address: |
639 Zhizaoju Road, Huangpu District, Shanghai Municipality |
Study leader's address: |
639 Zhizaoju Road, Huangpu District, Shanghai Municipality |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海交通大学医学院附属上海第九人民医院 |
||
|
Applicant's institution: |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
||
|
研究负责人所在单位: |
上海交通大学医学院附属上海第九人民医院 |
||
|
Affiliation of the Leader: |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
SH9H-2024-T440-1 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海交通大学医学院附属第九人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-01-09 00:00:00 |
||
|
伦理委员会联系人: |
甄红 |
||
|
Contact Name of the ethic committee: |
Zhen Hong |
||
|
伦理委员会联系地址: |
上海市市辖区黄浦区制造局路639号 |
||
|
Contact Address of the ethic committee: |
639 Zhizaoju Road, Huangpu District, Shanghai Municipality |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 23 281 699 5576 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海交通大学医学院附属上海第九人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市市辖区黄浦区制造局路639号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
639 Zhizaoju Road, Huangpu District, Shanghai Municipality |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金82170922 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation 82170922 |
||||||||||||||||||||||
|
Target disease: |
Dentition Defect |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
通过Er:YAG激光牙周膜切割辅助牙拔除术前与术后3个月CBCT,创面大小测量,肿胀程度测量和伤口愈合情况评分对比Er:YAG激光微创拔牙术与传统牙拔除术对患者拔牙创愈合与术中术后并发症的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to evaluate the impact of Er:YAG laser-assisted minimally invasive tooth extraction versus conventional tooth extraction on post-extraction alveolar wound healing and the incidence of intra-/postoperative complications. The comparative analysis is based on pre-operative and 3-month postoperative assessments, including CBCT scans, measurements of wound dimensions, evaluations of swelling levels, and wound healing scores. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1)因治疗需要拔除左右侧同名健康牙的患者;2)14-25岁(含上下限);3)患者咬合、牙槽骨等左右基本对称;4)无骨代谢性疾病、血液性疾病、精神类疾病及未被控制的系统性疾病;5)无吸烟史,患者依从性良好;6)患者愿意进行试验方案中要求的评价;7)患者同意签署经伦理委员会批准的知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Patients requiring extraction of bilateral homologous healthy teeth for therapeutic purposes. (2) Age between 14 and 25 years (inclusive). (3) General symmetry in occlusion and alveolar bone structure between left and right sides. (4) No history of bone metabolic diseases, hematological diseases, mental disorders, or uncontrolled systemic conditions. (5) No history of smoking, with good patient compliance. (6) Willingness to undergo all evaluations specified in the trial protocol. (7) Agreement to sign the informed consent form approved by the Ethics Committee |
||||||||||||||||||||||
|
排除标准: |
1)拔牙禁忌症;2)有骨代谢疾病、血液性疾病、精神类疾病及未被控制的系统性疾病,存在可能影响软硬组织愈合、出凝血水平及疼痛焦虑水平的药物应用;3)有外伤史,牙槽骨骨板骨折甚至缺失;4)处于任何疾病急性期的患者;5)有严重牙周疾病的患者;6)影像学资料不全或质量差者;7)不能配合治疗,依从性差的患者;8)酗酒或长期药物滥用者;9)有吸烟史。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Contraindications to tooth extraction. (2) Presence of bone metabolic diseases, hematological diseases, mental disorders, uncontrolled systemic diseases, or use of medications that may affect soft/hard tissue healing, coagulation function, or pain/anxiety levels. (3) History of trauma with alveolar bone plate fracture or defect. (4) Patients in the acute phase of any disease. (5) Patients with severe periodontal diseases. (6) Incomplete or poor-quality radiographic documentation. (7) Inability to cooperate with treatment or poor compliance. (8) History of alcohol abuse or long-term substance misuse. (9) History of smoking |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-07-01 00:00:00至 To 2026-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-07-11 00:00:00 至 To 2026-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由一位不参与患者招募和临床干预的研究人员使用随机数法产生随机序列 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The randomization sequence was generated by a researcher not involved in patient recruitment or clinical interventions using a random number method. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
对受试者和统计分析者设盲 |
|
Blinding: |
The subjects and statistical analysts were blinded. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
本研究的原始数据将在研究结束并发表后2年内进行共享。数据将以脱敏形式上传至临床试验原始数据共享平台(ResMan Research Manager),公开访问地址为:https://www.medresman.org 。上传内容包括个体参与者数据(IPD)及相应元数据,但不包含可识别个人信息。研究团队将在数据共享前完成严格的数据脱敏与质量核查。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The original data of this study will be shared within two years after the conclusion and publication of the research. Data will be uploaded in the form of desensitization to clinical trials original data sharing platform (ResMan Research Manager), public access address is: https://www.medresman.org. The uploaded content includes individual participant data (IPD) and corresponding metadata, but does not contain identifiable personal information. The research team will complete strict data desensitization and quality verification before data sharing. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究的数据采集基于统一设计的病例记录表(Case Record Form, CRF)完成,所有研究相关信息均由经过培训的研究人员按实际情况如实记录。 数据管理采用电子数据采集系统(Electronic Data Capture, EDC)ResMan Research Manager进行(https://www.medresman.org)。所有数据在输入后将由系统自动进行逻辑校验,并由研究团队进行多轮数据核查,以确保数据的准确性和完整性。系统具有权限管理、数据追踪和审计日志等功能,可保证数据安全、可追溯及符合伦理与法规要求。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The data collection of this study was completed based on the uniformly designed Case Record Form (CRF), and all research-related information was truthfully recorded by trained researchers according to the actual situation. Data management by Electronic Data acquisition system (Electronic Data Capture, EDC) ResMan Research Manager (https://www.medresman.org). All data will be automatically logically verified by the system after input, and the research team will conduct multiple rounds of data verification to ensure the accuracy and completeness of the data. The system features functions such as permission management, data tracking, and audit logs, which can ensure data security, traceability, and compliance with ethical and regulatory requirements |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |